AAAAAA

   
Results: 1-8 |
Results: 8
CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - 4 SYSTEMATIC METAANALYSES OF INDIVIDUAL PATIENT DATA FROM 39 RANDOMIZED TRIALS
Authors: AABO K ADAMS M ADNITT P ALBERTS DS ATHANAZZIOU A BARLEY V BELL DR BIANCHI U BOLIS G BRADY MF BRODOVSKY HS BRUCKNER H BUYSE M CANETTA R CHYLAK V COHEN CJ COLOMBO N CONTE PF CROWTHER D EDMONSON JH GENNATAS C GILBEY E GORE M GUTHRIE D KAYE SB LAING AH LANDONI F LEONARD RC LEWIS C LIU PY MANGIONI C MARSONI S MEERPOHL H OMURA GA PARMAR MKB PATER J PECORELLI S PRESTI M SAUERBREI W SKARLOS DV SMALLEY RV SOLOMON HJ STEWART LA STURGEON JFG TATTERSALL MHN WHARTON JT HUININK WWT TOMIROTTI M TORRI W TROPE C TURBOW MM VERMORKEN JB WEBB MJ WILBUR DW WILLIAMS CJ WILTSHAW E YEAP BY
Citation: K. Aabo et al., CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - 4 SYSTEMATIC METAANALYSES OF INDIVIDUAL PATIENT DATA FROM 39 RANDOMIZED TRIALS, British Journal of Cancer, 78(11), 1998, pp. 1479-1487
LONG-TERM TOXICITY IN ADJUVANT TREATMENT WITH TAMOXIFEN
Authors: COBELLI S DAMBROSIO M FARINA G ROVEJ R TOMIROTTI M SCANNI A
Citation: S. Cobelli et al., LONG-TERM TOXICITY IN ADJUVANT TREATMENT WITH TAMOXIFEN, Journal of chemotherapy, 9(4), 1997, pp. 300-303
CIS CARBOPLATIN PLUS VINORELBINE +/- RADIOTHERAPY IN STAGE-III AND STAGE-IV NON-SMALL-CELL LUNG-CARCINOMA/
Authors: TOMIROTTI M GALASSI B DAMBROSIO M FOSSATI V GRAMEGNA G COLOMBO F ROVEJ R SCANNI A
Citation: M. Tomirotti et al., CIS CARBOPLATIN PLUS VINORELBINE +/- RADIOTHERAPY IN STAGE-III AND STAGE-IV NON-SMALL-CELL LUNG-CARCINOMA/, Journal of chemotherapy, 9(1), 1997, pp. 62-65
TAMOXIFEN (TAM) IN BREAST-CANCER (BC) - TOXICITY OF LONG-TERM ADJUVANT TREATMENT
Authors: MANTICA C LAVERDE N FARINA G COBELLI S DAMBROSIO M PERRONE S TOMIROTTI M SCANNI A
Citation: C. Mantica et al., TAMOXIFEN (TAM) IN BREAST-CANCER (BC) - TOXICITY OF LONG-TERM ADJUVANT TREATMENT, European journal of cancer, 31A, 1995, pp. 59-59
EFFICACY AND TOLERABILITY OF NASALLY ADMINISTERED COMPARED TO PARENTERALLY ADMINISTERED METOCLOPRAMIDE IN THE SYMPTOMATIC TREATMENT OF CHEMOTHERAPY-INDUCED EMESIS IN CANCER OUTPATIENTS - A CONTROLLED CLINICAL-STUDY
Authors: TOMIROTTI M DIMAIUTA M CONFALONIERI M SCANNI A
Citation: M. Tomirotti et al., EFFICACY AND TOLERABILITY OF NASALLY ADMINISTERED COMPARED TO PARENTERALLY ADMINISTERED METOCLOPRAMIDE IN THE SYMPTOMATIC TREATMENT OF CHEMOTHERAPY-INDUCED EMESIS IN CANCER OUTPATIENTS - A CONTROLLED CLINICAL-STUDY, Supportive care in cancer, 2(6), 1994, pp. 389-392
RECOVERY OF RESPONSE TO ADRIAMYCIN AND CYCLOPHOSPHAMIDE BY LONIDAMINEIN PREVIOUSLY TREATED METASTATIC BREAST-CANCER PATIENTS
Authors: TOMIROTTI M BERNARDO G EPIFANI C BIASIOLI R FRANCHI R MENSI F CARNAGHI P SCHIEPPATI G SCANNI A
Citation: M. Tomirotti et al., RECOVERY OF RESPONSE TO ADRIAMYCIN AND CYCLOPHOSPHAMIDE BY LONIDAMINEIN PREVIOUSLY TREATED METASTATIC BREAST-CANCER PATIENTS, International journal of oncology, 3(2), 1993, pp. 213-217
CONCURRENT CARBOPLATIN (CBDCA), VINDESINE (VDS) AND RADIOTHERAPY IN STAGE-III NON-SMALL-CELL LUNG-CANCER (NSCLC)
Authors: TOMIROTTI M GRAMEGNA G MANTELLINI P FOSSATI V MEZZETTI M DIMAIUTA M SCANNI A
Citation: M. Tomirotti et al., CONCURRENT CARBOPLATIN (CBDCA), VINDESINE (VDS) AND RADIOTHERAPY IN STAGE-III NON-SMALL-CELL LUNG-CANCER (NSCLC), Tumori, 79(1), 1993, pp. 49-57
PHARMACOKINETICS AND BIOAVAILABILITY OF METOCLOPRAMIDE NASAL SPRAY VERSUS METOCLOPRAMIDE INTRAVENOUS IN HEALTHY-VOLUNTEERS AND CANCER-PATIENTS
Authors: SCAGLIONE F SCANNI A TOMIROTTI M DIMAIUTA M FERRARI P FRASCHINI F
Citation: F. Scaglione et al., PHARMACOKINETICS AND BIOAVAILABILITY OF METOCLOPRAMIDE NASAL SPRAY VERSUS METOCLOPRAMIDE INTRAVENOUS IN HEALTHY-VOLUNTEERS AND CANCER-PATIENTS, Arzneimittel-Forschung, 43-2(9), 1993, pp. 986-988
Risultati: 1-8 |